Capturing Parkinson's Disease Medication Side Effects During Daily Activities

Great Lakes NeuroTechnologies Inc.15 enrolled

Overview

The purpose of the study is to test whether body-worn wireless motion sensors can measure dyskinesias (involuntary movements caused by medications) in individuals with Parkinson disease (PD) independent of voluntary activity being performed and other PD motor symptoms (e.g. tremor).

Study Type

OBSERVATIONAL

Enrollment

Conditions

Parkinson's Disease Dyskinesia

Eligibility

Sex: ALLMin age: 18 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Clinical diagnosis of probable or definite idiopathic Parkinson Disease with motor fluctuations that include dyskinesias after taking their usual dose of levodopa/carbidopa Exclusion Criteria: * Antipsychotic medications (including quetiapine and clozapine) * Coexisting neurologic disease such as stroke or dementia * Lacking capacity for informed consent * Residing in a nursing home * comorbid non-neurologic illnesses that impacts the ability to perform the study tasks * Implantable defibrillators

Locations (1)

University of Rochester Medical Center

Rochester, New York, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.